Mo Yang

机构：Hong Kong Polytechnic University, Southwest Petroleum University, Shenzhen Polytechnic University, Anhui University of Traditional Chinese Medicine, Tianjin Medical University General Hospital, Merck Serono S.A. (Switzerland), China Communications Construction Company (China), China Institute Of Communications, Merck Serono S.p.A. (Italy) · ORCID：0000-0002-3863-8187

发表论文 512 篇 · 总被引 12409 次 · h-index 57

代表论文

Thrombopoietin mitigates neuronal death by enhancing mitophagy and suppressing NLRP3 inflammasome activation under oxygen-glucose deprivation conditions (2025 · American Journal of Physiology-Cell Physiology · 被引 1)
Hemodynamic disruption triggers glomerular barrier injury via endothelial glycocalyx degradation in nephrotic syndrome (2026 · Biomedical Microdevices)
Persistence and adherence to tepotinib in patients with metastatic non-small cell lung cancer: a real-world evidence study including dose reductions (2026 · Figshare)
Persistence and adherence to tepotinib in patients with metastatic non-small cell lung cancer: a real-world evidence study including dose reductions (2026 · Figshare)
Persistence and adherence to tepotinib in patients with metastatic non-small cell lung cancer: a real-world evidence study including dose reductions (2026 · Future Oncology)
Applications of Wearable Sweat Biosensors in Sports Activities with Real-World Cases (2026 · Bioengineering)